ATE311907T1 - Anwendung von komplexen von kationischen liposomen und polydeoxyribonukleotiden wie arzneimitteln - Google Patents
Anwendung von komplexen von kationischen liposomen und polydeoxyribonukleotiden wie arzneimittelnInfo
- Publication number
- ATE311907T1 ATE311907T1 AT99111118T AT99111118T ATE311907T1 AT E311907 T1 ATE311907 T1 AT E311907T1 AT 99111118 T AT99111118 T AT 99111118T AT 99111118 T AT99111118 T AT 99111118T AT E311907 T1 ATE311907 T1 AT E311907T1
- Authority
- AT
- Austria
- Prior art keywords
- complexes
- polydeoxyribonucleotides
- cationic liposomes
- drugs
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99111118A EP1059092B1 (de) | 1999-06-08 | 1999-06-08 | Anwendung von Komplexen von kationischen Liposomen und Polydeoxyribonukleotiden wie Arzneimitteln |
CA002274419A CA2274419A1 (en) | 1999-06-08 | 1999-06-11 | Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
AU35010/99A AU776014B2 (en) | 1999-06-11 | 1999-06-11 | Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments |
US09/330,215 US6767554B2 (en) | 1999-06-08 | 1999-06-11 | Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments |
KR1019990021947A KR100676492B1 (ko) | 1999-06-08 | 1999-06-12 | 양이온성 리포솜 및 폴리데옥시리보누클레오티드 사이의 복합체의 약제로서의 용도 |
JP16700999A JP4598908B2 (ja) | 1999-06-08 | 1999-06-14 | カチオン性リポソームとポリデオキシリボヌクレオチドとの複合体 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE311907T1 true ATE311907T1 (de) | 2005-12-15 |
Family
ID=32330163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99111118T ATE311907T1 (de) | 1999-06-08 | 1999-06-08 | Anwendung von komplexen von kationischen liposomen und polydeoxyribonukleotiden wie arzneimitteln |
Country Status (9)
Country | Link |
---|---|
US (1) | US6767554B2 (de) |
EP (1) | EP1059092B1 (de) |
JP (1) | JP4598908B2 (de) |
KR (1) | KR100676492B1 (de) |
AT (1) | ATE311907T1 (de) |
CA (1) | CA2274419A1 (de) |
DE (1) | DE69928778T2 (de) |
DK (1) | DK1059092T3 (de) |
ES (1) | ES2251134T3 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4115833B2 (ja) * | 2000-10-12 | 2008-07-09 | ユニバーシティー、オブ、メディシン、アンド、デンティストリー、オブ、ニュージャージー | オリゴヌクレオチドが促進する合体 |
WO2004002468A1 (en) | 2002-06-26 | 2004-01-08 | Medigene Oncology Gmbh | Method of producing a cationic liposomal preparation comprising a lipophilic compound |
JP2006193461A (ja) * | 2005-01-13 | 2006-07-27 | Pola Chem Ind Inc | 毛髪用の洗浄料 |
ITMI20051303A1 (it) * | 2005-07-08 | 2007-01-09 | Inxel S R L | Metodo per la produzione di vernici in polvere termoindurenti particolarmente per l'applicazione mediante impianti elettrostatici |
EP1872787A1 (de) * | 2006-06-27 | 2008-01-02 | Gentium S.p.A. | Verwendung von Defibrotide als Heparanasehemmer |
WO2008093848A1 (ja) * | 2007-02-02 | 2008-08-07 | Sunstar Inc. | ホスファチジルコリンを含有する炎症マーカー低減組成物 |
EP2103689A1 (de) * | 2008-03-19 | 2009-09-23 | Gentium S.p.A. | Synthetische Phosphodiester-Oligonukleotide und deren therapeutische Verwendungen |
US20100279353A1 (en) * | 2009-04-30 | 2010-11-04 | Shiu Nan Chen | Process of producing fibrinolytic enzyme from mushroom |
JP5142295B2 (ja) * | 2009-05-08 | 2013-02-13 | 独立行政法人農業・食品産業技術総合研究機構 | ベシクル及びその製法 |
WO2010135714A2 (en) | 2009-05-22 | 2010-11-25 | The Methodist Hospital Research Institute | Methods for modulating adipocyte expression using microrna compositions |
JP6069209B2 (ja) | 2010-11-12 | 2017-02-01 | ジェンティウム ソシエタ ア レスポンサビリタ リミタータ | 移植片対宿主病(gvhd)の予防および/または治療に使用するためのデフィブロタイド |
GB201204632D0 (en) * | 2012-03-16 | 2012-05-02 | Univ Belfast | Delivery system |
RU2627177C2 (ru) | 2012-06-22 | 2017-08-03 | Джентиум С.Р.Л. | Способ определения биологической активности дефибротида, основанный на применении эуглобулина |
US11086970B2 (en) | 2013-03-13 | 2021-08-10 | Blue Belt Technologies, Inc. | Systems and methods for using generic anatomy models in surgical planning |
KR101534276B1 (ko) * | 2014-07-18 | 2015-07-07 | 주식회사 에스씨301테라피 | 지방 이식 수술 후 지방세포 성장 및 생착 증진을 위한 조성물 |
EP3026122A1 (de) | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Zellenbasiertes Verfahren zur Bestimmung der Wirksamkeit von Defibrotid |
JP2020530004A (ja) | 2017-08-03 | 2020-10-15 | ジャズ ファーマシューティカルズ アイルランド リミテッド | 核酸を高濃度で含む製剤 |
WO2019200251A1 (en) | 2018-04-12 | 2019-10-17 | Jazz Pharmaceuticals, Inc. | Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion |
KR102144615B1 (ko) * | 2018-08-09 | 2020-08-13 | 장건주 | 폴리데옥시리보뉴클레오타이드를 포함하는 마이셀, 약물 전달체 및 이의 제조방법 |
KR102132478B1 (ko) * | 2018-11-15 | 2020-07-10 | (주)진우바이오 | 히알루론산-폴리데옥시리보뉴클레오타이드 복합체와 이를 활용한 필름 및 이의 제조방법 |
US20220023533A1 (en) | 2018-12-07 | 2022-01-27 | Jazz Phrmaceticals Ireland Limited | Subcutaneous delivery of high concentration formulations |
KR20220070251A (ko) | 2019-09-26 | 2022-05-30 | 니치유 가부시키가이샤 | 지질 나노 입자의 동결 건조 조성물 |
US20230190783A1 (en) | 2020-02-28 | 2023-06-22 | Jazz Pharmaceuticals Ireland Limited | Delivery of low viscosity formulations |
WO2022234101A1 (en) | 2021-05-06 | 2022-11-10 | Jazz Pharmaceuticals Ireland Limited | Defibrotide for the treatment and prevention of acute respiratory distress syndrome |
CN115737470A (zh) * | 2022-11-25 | 2023-03-07 | 润辉生物技术(威海)有限公司 | 一种肌肽-pdrn复合物及其制备方法和应用 |
CN115836982B (zh) * | 2022-12-30 | 2024-02-06 | 南京乐韬生物科技有限公司 | 一种含pdrn的纳米乳液及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1043823B (it) | 1970-11-03 | 1980-02-29 | Prephar | Procedimento per l estrazione di acidi nucleici da organi animali |
DE3017154A1 (de) | 1980-05-05 | 1981-11-12 | Hoechst Ag, 6000 Frankfurt | Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3,-heptafluor-propan |
HU192909B (en) * | 1985-01-17 | 1987-07-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing interfuranylene-prostacycline derivatives |
IT1190313B (it) | 1986-04-17 | 1988-02-16 | Crinos Industria Farmaco | Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante |
JP2792702B2 (ja) * | 1988-10-05 | 1998-09-03 | ネクスター・フアーマシユーテイカルズ・インコーポレイテツド | 乾燥時に改善された安定性を示すリポソームの調製方法 |
DE69008521T2 (de) * | 1989-03-07 | 1994-10-20 | Genentech Inc | Kovalente konjugate von lipiden und oligonukleotiden. |
EP0451791A2 (de) * | 1990-04-12 | 1991-10-16 | Hoechst Aktiengesellschaft | Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung |
EP0539989B1 (de) | 1991-11-01 | 1997-06-18 | SOLVAY (Société Anonyme) | Verfahren zur Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227) |
IT1252174B (it) * | 1991-12-09 | 1995-06-05 | Crinos Industria Farmaco | Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento |
ES2093872T3 (es) | 1992-03-26 | 1997-01-01 | Solvay | Procedimiento para la reactivacion de un catalizador de carbon activo empleado para la preparacion de 1,1,1,2,3,3,3-heptafluoropropano (r 227). |
US5395619A (en) * | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
DE4323054A1 (de) | 1993-07-14 | 1995-01-19 | Hoechst Ag | Verfahren zur Herstellung von 2-H-Heptafluorpropan |
US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
US5908777A (en) * | 1995-06-23 | 1999-06-01 | University Of Pittsburgh | Lipidic vector for nucleic acid delivery |
DE69629702T2 (de) * | 1995-08-01 | 2004-06-17 | Isis Pharmaceuticals, Inc., Carlsbad | Liposomale oligonukleotidzusammensetzungen |
US5837283A (en) * | 1997-03-12 | 1998-11-17 | The Regents Of The University Of California | Cationic lipid compositions targeting angiogenic endothelial cells |
-
1999
- 1999-06-08 DE DE69928778T patent/DE69928778T2/de not_active Expired - Lifetime
- 1999-06-08 ES ES99111118T patent/ES2251134T3/es not_active Expired - Lifetime
- 1999-06-08 EP EP99111118A patent/EP1059092B1/de not_active Expired - Lifetime
- 1999-06-08 AT AT99111118T patent/ATE311907T1/de active
- 1999-06-08 DK DK99111118T patent/DK1059092T3/da active
- 1999-06-11 US US09/330,215 patent/US6767554B2/en not_active Expired - Lifetime
- 1999-06-11 CA CA002274419A patent/CA2274419A1/en not_active Abandoned
- 1999-06-12 KR KR1019990021947A patent/KR100676492B1/ko not_active IP Right Cessation
- 1999-06-14 JP JP16700999A patent/JP4598908B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2001002565A (ja) | 2001-01-09 |
KR20010002244A (ko) | 2001-01-15 |
ES2251134T3 (es) | 2006-04-16 |
KR100676492B1 (ko) | 2007-01-30 |
US20020142029A1 (en) | 2002-10-03 |
EP1059092B1 (de) | 2005-12-07 |
EP1059092A1 (de) | 2000-12-13 |
DE69928778T2 (de) | 2006-07-06 |
DE69928778D1 (de) | 2006-01-12 |
CA2274419A1 (en) | 2000-12-11 |
JP4598908B2 (ja) | 2010-12-15 |
US6767554B2 (en) | 2004-07-27 |
DK1059092T3 (da) | 2006-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE311907T1 (de) | Anwendung von komplexen von kationischen liposomen und polydeoxyribonukleotiden wie arzneimitteln | |
ES2054678T3 (es) | Conjugados estrella. | |
DE60033179D1 (de) | Modifizierte polymere hergestellt mit katalysatoren auf basis von lanthaniden | |
DE69815075D1 (de) | Dimere kationische lipide auf dicystinbasis | |
EE200200064A (et) | Arüülmetüülkarbonüülaminotiasooli derivaadid, nende valmistamine ja kasutamine vähivastaste toimeainetena | |
WO2003015711A3 (en) | Combination motif immune stimulatory oligonucleotides with improved activity | |
FR2781667B1 (fr) | Patch cosmetique, pharmaceutique, ou dermatologique | |
DE69912782D1 (de) | Molekulargewichtserhöhung von polyestern | |
CY1112361T1 (el) | Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743 | |
DE50003116D1 (de) | Neuartige arzneimittelkompositionen auf der basis von tiotropiumbromid und salmeterol | |
DE60233122D1 (de) | Ionensensitive kationische polymere und fasergegenstände mit diesen | |
FR2870741B1 (fr) | Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant. | |
FR2791678B1 (fr) | Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique | |
DE60002526D1 (de) | Herstellung von Tricyclodecandicarbaldehyd, Pentacyclopentadecandicarbaldehyd und der entsprechenden Dimethanole | |
ID30116A (id) | Turunan-turunan piridopiranoazepin, pembuatannya dan penggunaan terapinya | |
EE200000037A (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena | |
DE60028022D1 (de) | Herstellung von biologisch aktiven molekülen | |
DE69501530D1 (de) | Herstellung von trans-1,4-Polybutadien mit kontrolliertem Molekulargewicht | |
ID26612A (id) | Turunan-turunan siklobutena, pembuatannya dan penggunaan-penggunaan terapinya | |
SE9904377D0 (sv) | Pharmaceutical combinations | |
CA2361841A1 (en) | Mevinolin derivatives | |
DE60009708T2 (de) | Gewinnung von propan | |
IT1284002B1 (it) | Macchina circolare monocilindrica per calzetteria o maglieria particolarmente per la produzione di manufatti chiusi in | |
BR9800349A (pt) | Preparação de catalisadores à base de antimonato de vanádio utilizando sn02.xhs20 | |
DE69821984D1 (de) | Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1059092 Country of ref document: EP |